Berlin - Delayed Quote EUR
Revive Therapeutics Ltd (31R.BE)
0.0215
0.0000
(0.00%)
At close: May 27 at 7:31:03 PM GMT+2
Loading Chart for 31R.BE
- Previous Close
0.0215 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0265 - Volume
0 - Avg. Volume
4,939 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 28, 2025 - Jun 2, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 31R.BE
View MorePerformance Overview: 31R.BE
Trailing total returns as of 5/27/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
31R.BE
59.26%
S&P/TSX Composite index (^GSPTSE)
6.70%
1-Year Return
31R.BE
12.24%
S&P/TSX Composite index (^GSPTSE)
17.41%
3-Year Return
31R.BE
92.97%
S&P/TSX Composite index (^GSPTSE)
26.61%
5-Year Return
31R.BE
89.03%
S&P/TSX Composite index (^GSPTSE)
72.01%
Compare To: 31R.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.0215
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0300
0.00%
Mkt Cap CAD 12.028M
Industry Drug Manufacturers—Specialty & Generic
Statistics: 31R.BE
View MoreValuation Measures
As of 5/26/2025
Market Cap
6.70M
Enterprise Value
6.22M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
2.20
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--